ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antidiabetic Biguanides Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-33C6895
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Antidiabetic Biguanides Market Insights and Forecast to 2028
BUY CHAPTERS

Global Antidiabetic Biguanides Market Research Report 2025

Code: QYRE-Auto-33C6895
Report
August 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Astrazeneca plc
GlaxoSmithKline PLC
Merck
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol–Myers Squibb

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antidiabetic Biguanides Market

Antidiabetic Biguanides Market

The global market for Antidiabetic Biguanides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antidiabetic Biguanides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetic Biguanides.
The Antidiabetic Biguanides market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antidiabetic Biguanides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antidiabetic Biguanides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antidiabetic Biguanides Market Report

Report Metric Details
Report Name Antidiabetic Biguanides Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, AstraZeneca, GlaxoSmithKline, Merck & Co, Eli Lilly, Sanofi, Takeda Pharmaceuticals, Novo Nordisk, Servier Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antidiabetic Biguanides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antidiabetic Biguanides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Antidiabetic Biguanides Market report?

Ans: The main players in the Antidiabetic Biguanides Market are Pfizer, AstraZeneca, GlaxoSmithKline, Merck & Co, Eli Lilly, Sanofi, Takeda Pharmaceuticals, Novo Nordisk, Servier Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb

What are the Application segmentation covered in the Antidiabetic Biguanides Market report?

Ans: The Applications covered in the Antidiabetic Biguanides Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Antidiabetic Biguanides Market report?

Ans: The Types covered in the Antidiabetic Biguanides Market report are Metformin IR, Metformin SR

Recommended Reports

Diabetes & Metabolism

Urinary & Renal

Anti-infectives & Therapy

1 Antidiabetic Biguanides Market Overview
1.1 Product Definition
1.2 Antidiabetic Biguanides by Type
1.2.1 Global Antidiabetic Biguanides Market Value Comparison by Type (2024 VS 2031)
1.2.2 Metformin IR
1.2.3 Metformin SR
1.3 Antidiabetic Biguanides by Application
1.3.1 Global Antidiabetic Biguanides Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Antidiabetic Biguanides Market Size Estimates and Forecasts
1.4.1 Global Antidiabetic Biguanides Revenue 2020-2031
1.4.2 Global Antidiabetic Biguanides Sales 2020-2031
1.4.3 Global Antidiabetic Biguanides Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antidiabetic Biguanides Market Competition by Manufacturers
2.1 Global Antidiabetic Biguanides Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antidiabetic Biguanides Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antidiabetic Biguanides Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antidiabetic Biguanides, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antidiabetic Biguanides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antidiabetic Biguanides, Product Type & Application
2.7 Global Key Manufacturers of Antidiabetic Biguanides, Date of Enter into This Industry
2.8 Global Antidiabetic Biguanides Market Competitive Situation and Trends
2.8.1 Global Antidiabetic Biguanides Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antidiabetic Biguanides Players Market Share by Revenue
2.8.3 Global Antidiabetic Biguanides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antidiabetic Biguanides Market Scenario by Region
3.1 Global Antidiabetic Biguanides Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antidiabetic Biguanides Sales by Region: 2020-2031
3.2.1 Global Antidiabetic Biguanides Sales by Region: 2020-2025
3.2.2 Global Antidiabetic Biguanides Sales by Region: 2026-2031
3.3 Global Antidiabetic Biguanides Revenue by Region: 2020-2031
3.3.1 Global Antidiabetic Biguanides Revenue by Region: 2020-2025
3.3.2 Global Antidiabetic Biguanides Revenue by Region: 2026-2031
3.4 North America Antidiabetic Biguanides Market Facts & Figures by Country
3.4.1 North America Antidiabetic Biguanides Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antidiabetic Biguanides Sales by Country (2020-2031)
3.4.3 North America Antidiabetic Biguanides Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antidiabetic Biguanides Market Facts & Figures by Country
3.5.1 Europe Antidiabetic Biguanides Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antidiabetic Biguanides Sales by Country (2020-2031)
3.5.3 Europe Antidiabetic Biguanides Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antidiabetic Biguanides Market Facts & Figures by Region
3.6.1 Asia Pacific Antidiabetic Biguanides Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antidiabetic Biguanides Sales by Region (2020-2031)
3.6.3 Asia Pacific Antidiabetic Biguanides Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antidiabetic Biguanides Market Facts & Figures by Country
3.7.1 Latin America Antidiabetic Biguanides Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antidiabetic Biguanides Sales by Country (2020-2031)
3.7.3 Latin America Antidiabetic Biguanides Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antidiabetic Biguanides Market Facts & Figures by Country
3.8.1 Middle East and Africa Antidiabetic Biguanides Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antidiabetic Biguanides Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antidiabetic Biguanides Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antidiabetic Biguanides Sales by Type (2020-2031)
4.1.1 Global Antidiabetic Biguanides Sales by Type (2020-2025)
4.1.2 Global Antidiabetic Biguanides Sales by Type (2026-2031)
4.1.3 Global Antidiabetic Biguanides Sales Market Share by Type (2020-2031)
4.2 Global Antidiabetic Biguanides Revenue by Type (2020-2031)
4.2.1 Global Antidiabetic Biguanides Revenue by Type (2020-2025)
4.2.2 Global Antidiabetic Biguanides Revenue by Type (2026-2031)
4.2.3 Global Antidiabetic Biguanides Revenue Market Share by Type (2020-2031)
4.3 Global Antidiabetic Biguanides Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antidiabetic Biguanides Sales by Application (2020-2031)
5.1.1 Global Antidiabetic Biguanides Sales by Application (2020-2025)
5.1.2 Global Antidiabetic Biguanides Sales by Application (2026-2031)
5.1.3 Global Antidiabetic Biguanides Sales Market Share by Application (2020-2031)
5.2 Global Antidiabetic Biguanides Revenue by Application (2020-2031)
5.2.1 Global Antidiabetic Biguanides Revenue by Application (2020-2025)
5.2.2 Global Antidiabetic Biguanides Revenue by Application (2026-2031)
5.2.3 Global Antidiabetic Biguanides Revenue Market Share by Application (2020-2031)
5.3 Global Antidiabetic Biguanides Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Antidiabetic Biguanides Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Antidiabetic Biguanides Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Antidiabetic Biguanides Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Merck & Co
6.4.1 Merck & Co Company Information
6.4.2 Merck & Co Description and Business Overview
6.4.3 Merck & Co Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck & Co Antidiabetic Biguanides Product Portfolio
6.4.5 Merck & Co Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Company Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly Antidiabetic Biguanides Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Antidiabetic Biguanides Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Takeda Pharmaceuticals
6.7.1 Takeda Pharmaceuticals Company Information
6.7.2 Takeda Pharmaceuticals Description and Business Overview
6.7.3 Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda Pharmaceuticals Antidiabetic Biguanides Product Portfolio
6.7.5 Takeda Pharmaceuticals Recent Developments/Updates
6.8 Novo Nordisk
6.8.1 Novo Nordisk Company Information
6.8.2 Novo Nordisk Description and Business Overview
6.8.3 Novo Nordisk Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novo Nordisk Antidiabetic Biguanides Product Portfolio
6.8.5 Novo Nordisk Recent Developments/Updates
6.9 Servier Laboratories
6.9.1 Servier Laboratories Company Information
6.9.2 Servier Laboratories Description and Business Overview
6.9.3 Servier Laboratories Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Servier Laboratories Antidiabetic Biguanides Product Portfolio
6.9.5 Servier Laboratories Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Company Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Boehringer Ingelheim Antidiabetic Biguanides Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 Bristol-Myers Squibb
6.11.1 Bristol-Myers Squibb Company Information
6.11.2 Bristol-Myers Squibb Description and Business Overview
6.11.3 Bristol-Myers Squibb Antidiabetic Biguanides Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bristol-Myers Squibb Antidiabetic Biguanides Product Portfolio
6.11.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antidiabetic Biguanides Industry Chain Analysis
7.2 Antidiabetic Biguanides Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antidiabetic Biguanides Production Mode & Process Analysis
7.4 Antidiabetic Biguanides Sales and Marketing
7.4.1 Antidiabetic Biguanides Sales Channels
7.4.2 Antidiabetic Biguanides Distributors
7.5 Antidiabetic Biguanides Customer Analysis
8 Antidiabetic Biguanides Market Dynamics
8.1 Antidiabetic Biguanides Industry Trends
8.2 Antidiabetic Biguanides Market Drivers
8.3 Antidiabetic Biguanides Market Challenges
8.4 Antidiabetic Biguanides Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Astrazeneca plc
GlaxoSmithKline PLC
Merck
Eli Lilly
Sanofi
Takeda Pharmaceuticals
Novo Nordisk
Servier Laboratories
Boehringer Ingelheim
Bristol–Myers Squibb
List of Tables
 Table 1. Global Antidiabetic Biguanides Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antidiabetic Biguanides Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antidiabetic Biguanides Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antidiabetic Biguanides Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Antidiabetic Biguanides Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antidiabetic Biguanides Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antidiabetic Biguanides Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antidiabetic Biguanides Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antidiabetic Biguanides, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antidiabetic Biguanides, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antidiabetic Biguanides, Product Type & Application
 Table 12. Global Key Manufacturers of Antidiabetic Biguanides, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antidiabetic Biguanides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetic Biguanides as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antidiabetic Biguanides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antidiabetic Biguanides Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Antidiabetic Biguanides Sales Market Share by Region (2020-2025)
 Table 19. Global Antidiabetic Biguanides Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Antidiabetic Biguanides Sales Market Share by Region (2026-2031)
 Table 21. Global Antidiabetic Biguanides Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antidiabetic Biguanides Revenue Market Share by Region (2020-2025)
 Table 23. Global Antidiabetic Biguanides Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antidiabetic Biguanides Revenue Market Share by Region (2026-2031)
 Table 25. North America Antidiabetic Biguanides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antidiabetic Biguanides Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Antidiabetic Biguanides Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Antidiabetic Biguanides Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antidiabetic Biguanides Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antidiabetic Biguanides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antidiabetic Biguanides Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Antidiabetic Biguanides Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Antidiabetic Biguanides Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antidiabetic Biguanides Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antidiabetic Biguanides Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antidiabetic Biguanides Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Antidiabetic Biguanides Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Antidiabetic Biguanides Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antidiabetic Biguanides Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antidiabetic Biguanides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antidiabetic Biguanides Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Antidiabetic Biguanides Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Antidiabetic Biguanides Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antidiabetic Biguanides Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antidiabetic Biguanides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antidiabetic Biguanides Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Antidiabetic Biguanides Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Antidiabetic Biguanides Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antidiabetic Biguanides Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antidiabetic Biguanides Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Antidiabetic Biguanides Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Antidiabetic Biguanides Sales Market Share by Type (2020-2025)
 Table 53. Global Antidiabetic Biguanides Sales Market Share by Type (2026-2031)
 Table 54. Global Antidiabetic Biguanides Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antidiabetic Biguanides Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antidiabetic Biguanides Revenue Market Share by Type (2020-2025)
 Table 57. Global Antidiabetic Biguanides Revenue Market Share by Type (2026-2031)
 Table 58. Global Antidiabetic Biguanides Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Antidiabetic Biguanides Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Antidiabetic Biguanides Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Antidiabetic Biguanides Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Antidiabetic Biguanides Sales Market Share by Application (2020-2025)
 Table 63. Global Antidiabetic Biguanides Sales Market Share by Application (2026-2031)
 Table 64. Global Antidiabetic Biguanides Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antidiabetic Biguanides Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antidiabetic Biguanides Revenue Market Share by Application (2020-2025)
 Table 67. Global Antidiabetic Biguanides Revenue Market Share by Application (2026-2031)
 Table 68. Global Antidiabetic Biguanides Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Antidiabetic Biguanides Price (USD/Pcs) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Pfizer Antidiabetic Biguanides Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Antidiabetic Biguanides Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. GlaxoSmithKline Company Information
 Table 81. GlaxoSmithKline Description and Business Overview
 Table 82. GlaxoSmithKline Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline Antidiabetic Biguanides Product
 Table 84. GlaxoSmithKline Recent Developments/Updates
 Table 85. Merck & Co Company Information
 Table 86. Merck & Co Description and Business Overview
 Table 87. Merck & Co Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Merck & Co Antidiabetic Biguanides Product
 Table 89. Merck & Co Recent Developments/Updates
 Table 90. Eli Lilly Company Information
 Table 91. Eli Lilly Description and Business Overview
 Table 92. Eli Lilly Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Eli Lilly Antidiabetic Biguanides Product
 Table 94. Eli Lilly Recent Developments/Updates
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Sanofi Antidiabetic Biguanides Product
 Table 99. Sanofi Recent Developments/Updates
 Table 100. Takeda Pharmaceuticals Company Information
 Table 101. Takeda Pharmaceuticals Description and Business Overview
 Table 102. Takeda Pharmaceuticals Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Takeda Pharmaceuticals Antidiabetic Biguanides Product
 Table 104. Takeda Pharmaceuticals Recent Developments/Updates
 Table 105. Novo Nordisk Company Information
 Table 106. Novo Nordisk Description and Business Overview
 Table 107. Novo Nordisk Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Novo Nordisk Antidiabetic Biguanides Product
 Table 109. Novo Nordisk Recent Developments/Updates
 Table 110. Servier Laboratories Company Information
 Table 111. Servier Laboratories Description and Business Overview
 Table 112. Servier Laboratories Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Servier Laboratories Antidiabetic Biguanides Product
 Table 114. Servier Laboratories Recent Developments/Updates
 Table 115. Boehringer Ingelheim Company Information
 Table 116. Boehringer Ingelheim Description and Business Overview
 Table 117. Boehringer Ingelheim Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Boehringer Ingelheim Antidiabetic Biguanides Product
 Table 119. Boehringer Ingelheim Recent Developments/Updates
 Table 120. Bristol-Myers Squibb Company Information
 Table 121. Bristol-Myers Squibb Description and Business Overview
 Table 122. Bristol-Myers Squibb Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Bristol-Myers Squibb Antidiabetic Biguanides Product
 Table 124. Bristol-Myers Squibb Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Antidiabetic Biguanides Distributors List
 Table 128. Antidiabetic Biguanides Customers List
 Table 129. Antidiabetic Biguanides Market Trends
 Table 130. Antidiabetic Biguanides Market Drivers
 Table 131. Antidiabetic Biguanides Market Challenges
 Table 132. Antidiabetic Biguanides Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antidiabetic Biguanides
 Figure 2. Global Antidiabetic Biguanides Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antidiabetic Biguanides Market Share by Type: 2024 & 2031
 Figure 4. Metformin IR Product Picture
 Figure 5. Metformin SR Product Picture
 Figure 6. Global Antidiabetic Biguanides Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Antidiabetic Biguanides Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Other
 Figure 11. Global Antidiabetic Biguanides Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Antidiabetic Biguanides Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Antidiabetic Biguanides Sales (2020-2031) & (K Pcs)
 Figure 14. Global Antidiabetic Biguanides Average Price (USD/Pcs) & (2020-2031)
 Figure 15. Antidiabetic Biguanides Report Years Considered
 Figure 16. Antidiabetic Biguanides Sales Share by Manufacturers in 2024
 Figure 17. Global Antidiabetic Biguanides Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Antidiabetic Biguanides Players: Market Share by Revenue in Antidiabetic Biguanides in 2024
 Figure 19. Antidiabetic Biguanides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Antidiabetic Biguanides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Antidiabetic Biguanides Sales Market Share by Country (2020-2031)
 Figure 22. North America Antidiabetic Biguanides Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Antidiabetic Biguanides Sales Market Share by Country (2020-2031)
 Figure 26. Europe Antidiabetic Biguanides Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Antidiabetic Biguanides Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Antidiabetic Biguanides Revenue Market Share by Region (2020-2031)
 Figure 34. China Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Antidiabetic Biguanides Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Antidiabetic Biguanides Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Antidiabetic Biguanides Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Antidiabetic Biguanides Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Antidiabetic Biguanides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Antidiabetic Biguanides by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Antidiabetic Biguanides by Type (2020-2031)
 Figure 55. Global Antidiabetic Biguanides Price (USD/Pcs) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Antidiabetic Biguanides by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Antidiabetic Biguanides by Application (2020-2031)
 Figure 58. Global Antidiabetic Biguanides Price (USD/Pcs) by Application (2020-2031)
 Figure 59. Antidiabetic Biguanides Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Antidiabetic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidiabetic Sulphonylureas Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidiabetic Combination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Incretin Based Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Combination Anti Diabetes Drugs Market Research Report 2025
Antidiabetic Thiazolidinediones Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Insulin Therapies for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Type 2 Diabetes Therapeutics Market Research Report 2025
Global Diabetic Therapeutic Drugs Market Research Report 2025
Glycemic Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Diarrheal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti diarrheal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diet Pills Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antidiarrheals Market Insights Forecast to 2030
Metformin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Insulin Hypoglycemic Drug Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions